IL160881A0 - Method for treating hepatitis c virus infection in treatment failure patients - Google Patents

Method for treating hepatitis c virus infection in treatment failure patients

Info

Publication number
IL160881A0
IL160881A0 IL16088102A IL16088102A IL160881A0 IL 160881 A0 IL160881 A0 IL 160881A0 IL 16088102 A IL16088102 A IL 16088102A IL 16088102 A IL16088102 A IL 16088102A IL 160881 A0 IL160881 A0 IL 160881A0
Authority
IL
Israel
Prior art keywords
virus infection
treating hepatitis
failure patients
treatment failure
hepatitis
Prior art date
Application number
IL16088102A
Other languages
English (en)
Original Assignee
Intermune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc filed Critical Intermune Inc
Publication of IL160881A0 publication Critical patent/IL160881A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16088102A 2001-09-28 2002-09-24 Method for treating hepatitis c virus infection in treatment failure patients IL160881A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32608801P 2001-09-28 2001-09-28
PCT/US2002/030445 WO2003028755A1 (en) 2001-09-28 2002-09-24 Method for treating hepatitis c virus infection in treatment failure patients

Publications (1)

Publication Number Publication Date
IL160881A0 true IL160881A0 (en) 2004-08-31

Family

ID=23270769

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16088102A IL160881A0 (en) 2001-09-28 2002-09-24 Method for treating hepatitis c virus infection in treatment failure patients

Country Status (15)

Country Link
US (1) US20050031586A1 (xx)
EP (1) EP1435998A4 (xx)
JP (1) JP2005508342A (xx)
KR (1) KR20040045022A (xx)
CN (1) CN1558771A (xx)
AR (1) AR036697A1 (xx)
BR (1) BR0212917A (xx)
CA (1) CA2460589A1 (xx)
HU (1) HUP0401657A2 (xx)
IL (1) IL160881A0 (xx)
MX (1) MXPA04002724A (xx)
NO (1) NO20041855L (xx)
PL (2) PL369129A1 (xx)
WO (1) WO2003028755A1 (xx)
ZA (1) ZA200402232B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1660116A4 (en) * 2003-08-13 2008-04-30 Smith Howard J & Ass Pty Ltd METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US20090246171A1 (en) * 2008-03-27 2009-10-01 Van Antwerp William P Automatic system for dose control in treating hepatitis c using infusion pumps
EP2286359A2 (en) * 2008-03-27 2011-02-23 Medtronic, Inc. Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools
CA2740864A1 (en) 2008-11-17 2010-05-20 F. Hoffmann-La Roche Ag Naphthylacetic acids
WO2011014882A1 (en) 2009-07-31 2011-02-03 Medtronic, Inc. CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
UY34402A (es) 2011-10-21 2013-05-31 Abbvie Inc Métodos para el tratamiento de hcv
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN104023726A (zh) 2011-10-21 2014-09-03 艾伯维公司 用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333)
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5980884A (en) * 1996-02-05 1999-11-09 Amgen, Inc. Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
US5980554A (en) * 1997-05-05 1999-11-09 Micro Therapeutics, Inc. Wire frame partial flow obstruction for aneurysm treatment
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US6127046A (en) * 1997-12-04 2000-10-03 Cummins Engine Company, Inc. Formation of a graphite-free surface in a ferrous material to produce an improved intermetallic bond

Also Published As

Publication number Publication date
EP1435998A1 (en) 2004-07-14
PL368718A1 (en) 2005-04-04
CA2460589A1 (en) 2003-04-10
BR0212917A (pt) 2004-12-21
ZA200402232B (en) 2005-03-22
KR20040045022A (ko) 2004-05-31
WO2003028755A1 (en) 2003-04-10
PL369129A1 (en) 2005-04-18
NO20041855L (no) 2004-04-27
HUP0401657A2 (hu) 2004-11-29
US20050031586A1 (en) 2005-02-10
JP2005508342A (ja) 2005-03-31
CN1558771A (zh) 2004-12-29
EP1435998A4 (en) 2005-03-02
MXPA04002724A (es) 2004-07-05
AR036697A1 (es) 2004-09-29

Similar Documents

Publication Publication Date Title
IL174796A0 (en) Methods for treating viral infection using-il-28 and il-29
IL164729A0 (en) Nucleoside derivatives for treating hepatitis c virus infection
EP1572097A4 (en) NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIONS WITH THE HEPATITIS C-VIRUS
AU2003251567A8 (en) Dialysis system for treatment of vulnerable patients and methods of use
IL155887A0 (en) Improved hemodialysis treatment apparatus and method
IL160881A0 (en) Method for treating hepatitis c virus infection in treatment failure patients
AU2002346686A1 (en) Compositions and method for treating hepatitis virus infection
AU2003274537A1 (en) Pyrrolidine derivatives for use in treating heaptitis c virus infection
IL157251A0 (en) Hepatitis b virus treatment
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
ZA200502307B (en) Method for treating patients with massive blood loss
IL160882A0 (en) Method for treating hepatitis c virus infection in treatment failure patients
EP1525216A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION
AU2002324753A1 (en) Composition and method for treating viral infection
HK1041837A1 (en) Method and apparatus for constituting blood loop for medical treatment.
AU2002365168A8 (en) Method and composition for treating and preventing hiv infection and aids
EP1581149A4 (en) METHOD OF TREATING PATIENTS FOR EXPOSURE TO RADIATION
AU2003254129A8 (en) Method and composition for treating and preventing hepatitis b infection and symptoms thereof
AU2001277055A1 (en) Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
AU2003256678A8 (en) Method and composition for treating and preventing hepatitis c infection
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
EP1589994A4 (en) PREPARATION AND METHOD FOR PREVENTING OR TREATING VIRAL INFECTION
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
AU2003299493A8 (en) Compositions and methods for the treatment of hepatitis c virus infection
HUP0000207A2 (hu) Készítmény és eljárás Sclerotinia-fertőzés kezelésére